Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24098178 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Federica Aliquò und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Dental Sciences and Morphofunctional Images, University of Messina, Via C. Valeria, 98125 Messina, Italy. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, RNA, Long Noncoding. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Messina.
Abstract (Originalsprache)
Endocan is a circulating proteoglycan secreted by several cell lines and identified as a potential biomarker of inflammation and angiogenesis. Endocan-increased expression has been found in a broad spectrum of human tumors, including lung cancer, and is associated with a poor prognosis. To elucidate the possible mechanism, this study aimed to investigate the role of endocan in non-small-cell lung carcinoma (NSCLC) using an in vitro model of cultured cells. Endocan expression was knocked down by using a specific small interfering RNA. The effects of endocan knockdown have been evaluated on VEGF-A, VEGFR-2, HIF-1α, the long non-coding RNAs H19 and HULC expression, and AKT and ERK 1/2 degree of activation. Cell migration and proliferation have been studied as well. VEGF-A, VEGFR-2, HIF-1α, and the long non-coding RNAs H19 and HULC expression were significantly affected by endocan knockdown. These effects correlated with a reduction of cell migration and proliferation and of AKT and ERK 1/2 activation. Our findings suggest that endocan promotes a more aggressive cancer cell phenotype in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Dental Sciences and Morphofunctional Images, University of Messina, Via C. Valeria, 98125 Messina, Italy.
- Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.
ORCID-Profile: Giuseppe Mandraffino, Angela D'Ascola
Förderung
- University of Messina
Zitieren
APA
Aliquò, F., Minuti, A., Avenoso, A., Mandraffino, G., Campo, G. M., Campo, S., D'Ascola, A., & Scuruchi, M. (2023). Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098178
Vancouver
Aliquò F, Minuti A, Avenoso A, Mandraffino G, Campo GM, Campo S, et al. Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098178
BibTeX
@article{Aliqu2023,
author = {Aliquò, Federica and Minuti, Aurelio and Avenoso, Angela and Mandraffino, Giuseppe and Campo, Giuseppe Maurizio and Campo, Salvatore and D'Ascola, Angela and Scuruchi, Michele},
title = {Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24098178}
}
EUVIMED